 |
 |

Neuropeptides and Central Nervous System InjuryClinical Implications
Alan I. Faden, MD
Arch Neurol. 1986;43(5):501-504.
Abstract
It has been proposed that endogenous opioids play a pathophysiologic role in the secondary injury that follows spinal trauma, brain trauma, and cerebral ischemia. Opiate antagonists, at high doses, have been found to improve outcome in various experimental models of central nervous system injury. Thyrotropinreleasing hormone, which appears to act in part as a functional antagonist of opioid systems, has proved effective in the treatment of experimental spinal cord and brain trauma. The literature relating to these developments is reviewed, with emphasis on the potential clinical application of these classes of substances.
Author Affiliations
From the Center for Neural Injury, San Francisco Veterans Administration Medical Center, and the Department of Neurology, University of California at San Francisco.
Footnotes
Accepted for publication Dec 19, 1985.
Reprint requests to Department of Neurology (127), San Francisco Veterans Administration Medical Center, 4150 Clement St, San Francisco, CA 94121 (Dr Faden).
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
Cervene (Nalmefene) in Acute Ischemic Stroke : Final Results of a Phase III Efficacy Study
Clark et al.
Stroke 2000;31:1234-1239.
ABSTRACT
| FULL TEXT
Fentanyl Does Not Increase Brain Injury After Focal Cerebral Ischemia in Rats
Soonthon-Brant et al.
Anesth. Analg. 1999;88:49-55.
ABSTRACT
| FULL TEXT
|